The drug ABELCET contains one active pharmaceutical ingredient (API):
Amphotericin B is a macrocyclic, polyene antifungal antibiotic produced by Streptomyces nodosus. The molecule is thought to act by binding to sterols in the fungal cell membrane, with a resulting change in membrane permeability, allowing leakage of a variety of small molecules.
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
This brand name is authorized in the following countries: Brazil Canada Spain France Mexico Netherlands Poland United Kingdom United States
This drug has been assigned below unique identifiers within the countries it is being marketed: